People · Operator
Named in public records as an officer, director or promoter · active 2017–2025 · Other Technology, Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Vence Corp | — | Other Technology | Series A | $9.6M | $161.5M | 2017 |
| Arkea Bio Corp. | — | Biotech / Pharma | Series A | $7.0M | $20.5M | 2025 |
Frank Wooten at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Frank Wooten on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Dhiraj Singh | 1 | 9 |
| Chris Rivest | 1 | 5 |
| SKY KURTZ | 1 | 3 |
| Zachariah Serber | 1 | 2 |
| JASPER HOLDSWORTH | 1 | 2 |
| Patrick Singler | 1 | 1 |
| Richard OGorman | 1 | 1 |
| Wayne McNee | 1 | 1 |
| CURT ROBERT | 1 | 1 |
| Tony Chao | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.